Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TECHNETIUM TC-99M SESTAMIBI: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

59.1%
Female
40.9%
Male

Age Information

The average age of patients reporting adverse events with TECHNETIUM TC-99M SESTAMIBI is 64.1 years.

Geographic Distribution

The majority of adverse event reports for TECHNETIUM TC-99M SESTAMIBI originate from US.

Report Summary & Outcomes

358
Total Reports
358
As Primary/Secondary Suspect
1
Deaths Reported
30
Hospitalizations
10
Life-Threatening
2
Disabilities

Reporting Timeline

First adverse event report: 20040719. Most recent report: 20250827. View full timeline →

More About TECHNETIUM TC-99M SESTAMIBI

TECHNETIUM TC-99M SESTAMIBI Full Profile Reports by Year Drug Interactions